| UniProt ID | LATS1_HUMAN | |
|---|---|---|
| UniProt AC | O95835 | |
| Protein Name | Serine/threonine-protein kinase LATS1 | |
| Gene Name | LATS1 {ECO:0000312|EMBL:AAD16882.1} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 1130 | |
| Subcellular Localization | Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Localizes to the centrosomes throughout interphase but migrates to the mitotic apparatus, including spindle pole bodies, mitotic spindle, and midbody, during mitosis. | |
| Protein Description | Negative regulator of YAP1 in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS1 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. Acts as a tumor suppressor which plays a critical role in maintenance of ploidy through its actions in both mitotic progression and the G1 tetraploidy checkpoint. Negatively regulates G2/M transition by down-regulating CDK1 kinase activity. Involved in the control of p53 expression. Affects cytokinesis by regulating actin polymerization through negative modulation of LIMK1. May also play a role in endocrine function. Plays a role in mammary gland epithelial cells differentiation, both through the Hippo signaling pathway and the intracellular estrogen receptor signaling pathway by promoting the degradation of ESR1. [PubMed: 28068668] | |
| Protein Sequence | MKRSEKPEGYRQMRPKTFPASNYTVSSRQMLQEIRESLRNLSKPSDAAKAEHNMSKMSTEDPRQVRNPPKFGTHHKALQEIRNSLLPFANETNSSRSTSEVNPQMLQDLQAAGFDEDMVIQALQKTNNRSIEAAIEFISKMSYQDPRREQMAAAAARPINASMKPGNVQQSVNRKQSWKGSKESLVPQRHGPPLGESVAYHSESPNSQTDVGRPLSGSGISAFVQAHPSNGQRVNPPPPPQVRSVTPPPPPRGQTPPPRGTTPPPPSWEPNSQTKRYSGNMEYVISRISPVPPGAWQEGYPPPPLNTSPMNPPNQGQRGISSVPVGRQPIIMQSSSKFNFPSGRPGMQNGTGQTDFMIHQNVVPAGTVNRQPPPPYPLTAANGQSPSALQTGGSAAPSSYTNGSIPQSMMVPNRNSHNMELYNISVPGLQTNWPQSSSAPAQSSPSSGHEIPTWQPNIPVRSNSFNNPLGNRASHSANSQPSATTVTAITPAPIQQPVKSMRVLKPELQTALAPTHPSWIPQPIQTVQPSPFPEGTASNVTVMPPVAEAPNYQGPPPPYPKHLLHQNPSVPPYESISKPSKEDQPSLPKEDESEKSYENVDSGDKEKKQITTSPITVRKNKKDEERRESRIQSYSPQAFKFFMEQHVENVLKSHQQRLHRKKQLENEMMRVGLSQDAQDQMRKMLCQKESNYIRLKRAKMDKSMFVKIKTLGIGAFGEVCLARKVDTKALYATKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPESLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHPRQDSMDFSNEWGDPSSCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILFEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFSSDLRQQSASYIPKITHPTDTSNFDPVDPDKLWSDDNEEENVNDTLNGWYKNGKHPEHAFYEFTFRRFFDDNGYPYNYPKPIEYEYINSQGSEQQSDEDDQNTGSEIKNRDLVYV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 17 | Phosphorylation | YRQMRPKTFPASNYT CCCCCCCCCCCCCCC | 37.22 | 22617229 | |
| 21 | Phosphorylation | RPKTFPASNYTVSSR CCCCCCCCCCCCCHH | 30.52 | 23186163 | |
| 23 | Phosphorylation | KTFPASNYTVSSRQM CCCCCCCCCCCHHHH | 13.16 | 23403867 | |
| 26 | Phosphorylation | PASNYTVSSRQMLQE CCCCCCCCHHHHHHH | 16.41 | - | |
| 27 | Phosphorylation | ASNYTVSSRQMLQEI CCCCCCCHHHHHHHH | 23.38 | - | |
| 37 | Phosphorylation | MLQEIRESLRNLSKP HHHHHHHHHHHCCCH | 23.84 | 24719451 | |
| 42 | Phosphorylation | RESLRNLSKPSDAAK HHHHHHCCCHHHHHH | 46.17 | 21712546 | |
| 76 | Ubiquitination | PKFGTHHKALQEIRN CCCCCHHHHHHHHHH | 43.09 | 29967540 | |
| 84 | Phosphorylation | ALQEIRNSLLPFANE HHHHHHHHHHHHCCC | 22.79 | 27050516 | |
| 92 | Phosphorylation | LLPFANETNSSRSTS HHHHCCCCCCCCCCC | 39.96 | 26546556 | |
| 94 | Phosphorylation | PFANETNSSRSTSEV HHCCCCCCCCCCCCC | 34.25 | 26546556 | |
| 139 | Phosphorylation | EAAIEFISKMSYQDP HHHHHHHHHCCCCCH | 27.85 | 28270605 | |
| 142 | Phosphorylation | IEFISKMSYQDPRRE HHHHHHCCCCCHHHH | 24.31 | 28270605 | |
| 143 | Phosphorylation | EFISKMSYQDPRREQ HHHHHCCCCCHHHHH | 17.28 | 28270605 | |
| 171 | Phosphorylation | KPGNVQQSVNRKQSW CCCCHHHHHCCCCCC | 12.31 | 24260401 | |
| 177 | Phosphorylation | QSVNRKQSWKGSKES HHHCCCCCCCCCHHH | 33.52 | 20363803 | |
| 181 | Phosphorylation | RKQSWKGSKESLVPQ CCCCCCCCHHHCCCC | 29.53 | 23927012 | |
| 184 | Phosphorylation | SWKGSKESLVPQRHG CCCCCHHHCCCCCCC | 38.10 | 27794612 | |
| 197 | Phosphorylation | HGPPLGESVAYHSES CCCCCCCCEEECCCC | 15.39 | 27174698 | |
| 200 | Phosphorylation | PLGESVAYHSESPNS CCCCCEEECCCCCCC | 12.06 | 27174698 | |
| 202 | Phosphorylation | GESVAYHSESPNSQT CCCEEECCCCCCCCC | 27.39 | 27174698 | |
| 204 | Phosphorylation | SVAYHSESPNSQTDV CEEECCCCCCCCCCC | 32.18 | 25159151 | |
| 207 | Phosphorylation | YHSESPNSQTDVGRP ECCCCCCCCCCCCCC | 37.53 | 27174698 | |
| 209 | Phosphorylation | SESPNSQTDVGRPLS CCCCCCCCCCCCCCC | 32.26 | 27174698 | |
| 216 | Phosphorylation | TDVGRPLSGSGISAF CCCCCCCCCCCCHHE | 33.33 | 27174698 | |
| 218 | Phosphorylation | VGRPLSGSGISAFVQ CCCCCCCCCCHHEEE | 29.58 | 27174698 | |
| 221 | Phosphorylation | PLSGSGISAFVQAHP CCCCCCCHHEEEECC | 21.12 | 27174698 | |
| 229 | Phosphorylation | AFVQAHPSNGQRVNP HEEEECCCCCCCCCC | 43.66 | 27174698 | |
| 243 | Methylation | PPPPPQVRSVTPPPP CCCCCCCCCCCCCCC | 21.84 | 115383981 | |
| 244 | Phosphorylation | PPPPQVRSVTPPPPP CCCCCCCCCCCCCCC | 31.33 | 30266825 | |
| 246 | Phosphorylation | PPQVRSVTPPPPPRG CCCCCCCCCCCCCCC | 31.18 | 30266825 | |
| 252 | Methylation | VTPPPPPRGQTPPPR CCCCCCCCCCCCCCC | 56.47 | 115481877 | |
| 255 | Phosphorylation | PPPPRGQTPPPRGTT CCCCCCCCCCCCCCC | 40.35 | 23911959 | |
| 259 | Methylation | RGQTPPPRGTTPPPP CCCCCCCCCCCCCCC | 61.95 | 115383989 | |
| 261 | Phosphorylation | QTPPPRGTTPPPPSW CCCCCCCCCCCCCCC | 37.09 | 18691976 | |
| 262 | Phosphorylation | TPPPRGTTPPPPSWE CCCCCCCCCCCCCCC | 36.30 | 25850435 | |
| 267 | Phosphorylation | GTTPPPPSWEPNSQT CCCCCCCCCCCCCCC | 50.25 | 23312004 | |
| 275 | Methylation | WEPNSQTKRYSGNME CCCCCCCCCCCCCCE | 41.52 | 115481885 | |
| 277 | Phosphorylation | PNSQTKRYSGNMEYV CCCCCCCCCCCCEEE | 23.61 | 23401153 | |
| 278 | Phosphorylation | NSQTKRYSGNMEYVI CCCCCCCCCCCEEEE | 27.94 | 23401153 | |
| 283 | Phosphorylation | RYSGNMEYVISRISP CCCCCCEEEEEEEEC | 7.72 | 23401153 | |
| 286 | Phosphorylation | GNMEYVISRISPVPP CCCEEEEEEEECCCC | 17.33 | 23401153 | |
| 289 | Phosphorylation | EYVISRISPVPPGAW EEEEEEEECCCCCCC | 20.80 | 26074081 | |
| 321 | Phosphorylation | NQGQRGISSVPVGRQ CCCCCCCCCCCCCCC | 28.27 | 28555341 | |
| 322 | Phosphorylation | QGQRGISSVPVGRQP CCCCCCCCCCCCCCC | 28.64 | 29457462 | |
| 334 | Phosphorylation | RQPIIMQSSSKFNFP CCCEEEECCCCCCCC | 21.14 | 17322306 | |
| 335 | Phosphorylation | QPIIMQSSSKFNFPS CCEEEECCCCCCCCC | 22.21 | 17322306 | |
| 336 | Phosphorylation | PIIMQSSSKFNFPSG CEEEECCCCCCCCCC | 46.65 | - | |
| 376 | Phosphorylation | NRQPPPPYPLTAANG CCCCCCCCCCCCCCC | 19.35 | 24043423 | |
| 379 | Phosphorylation | PPPPYPLTAANGQSP CCCCCCCCCCCCCCC | 21.15 | 24043423 | |
| 385 | Phosphorylation | LTAANGQSPSALQTG CCCCCCCCCCHHCCC | 23.40 | 24043423 | |
| 387 | Phosphorylation | AANGQSPSALQTGGS CCCCCCCCHHCCCCC | 47.02 | 24043423 | |
| 391 | Phosphorylation | QSPSALQTGGSAAPS CCCCHHCCCCCCCCC | 44.34 | 24043423 | |
| 394 | Phosphorylation | SALQTGGSAAPSSYT CHHCCCCCCCCCCCC | 23.70 | 19369195 | |
| 398 | Phosphorylation | TGGSAAPSSYTNGSI CCCCCCCCCCCCCCC | 31.11 | 24043423 | |
| 399 | Phosphorylation | GGSAAPSSYTNGSIP CCCCCCCCCCCCCCC | 34.61 | 24043423 | |
| 400 | Phosphorylation | GSAAPSSYTNGSIPQ CCCCCCCCCCCCCCH | 14.46 | 24043423 | |
| 401 | Phosphorylation | SAAPSSYTNGSIPQS CCCCCCCCCCCCCHH | 34.74 | 24043423 | |
| 404 | Phosphorylation | PSSYTNGSIPQSMMV CCCCCCCCCCHHHCC | 32.92 | 24043423 | |
| 408 | Phosphorylation | TNGSIPQSMMVPNRN CCCCCCHHHCCCCCC | 11.95 | 24043423 | |
| 462 | Phosphorylation | QPNIPVRSNSFNNPL CCCCCCCCCCCCCCC | 36.74 | 30266825 | |
| 464 | Phosphorylation | NIPVRSNSFNNPLGN CCCCCCCCCCCCCCC | 30.51 | 25159151 | |
| 490 | Phosphorylation | ATTVTAITPAPIQQP CCEEEEEECCCCCCC | 15.78 | 12372621 | |
| 573 | Phosphorylation | QNPSVPPYESISKPS CCCCCCCCCCCCCCC | 19.08 | 29978859 | |
| 575 | Phosphorylation | PSVPPYESISKPSKE CCCCCCCCCCCCCCC | 26.73 | 25627689 | |
| 577 | Phosphorylation | VPPYESISKPSKEDQ CCCCCCCCCCCCCCC | 48.03 | 29978859 | |
| 580 | Phosphorylation | YESISKPSKEDQPSL CCCCCCCCCCCCCCC | 53.03 | - | |
| 596 | Phosphorylation | KEDESEKSYENVDSG CCCCCHHHHCCCCCC | 33.36 | 28796482 | |
| 597 | Phosphorylation | EDESEKSYENVDSGD CCCCHHHHCCCCCCC | 23.69 | 28796482 | |
| 611 | Phosphorylation | DKEKKQITTSPITVR CHHHCCCCCCCEEEE | 20.80 | 22167270 | |
| 612 | Phosphorylation | KEKKQITTSPITVRK HHHCCCCCCCEEEEC | 33.85 | 29255136 | |
| 613 | Phosphorylation | EKKQITTSPITVRKN HHCCCCCCCEEEECC | 12.98 | 29255136 | |
| 616 | Phosphorylation | QITTSPITVRKNKKD CCCCCCEEEECCCCH | 20.03 | 23927012 | |
| 633 | Phosphorylation | RRESRIQSYSPQAFK HHHHHHHHHCHHHHH | 25.80 | 15688006 | |
| 635 | Phosphorylation | ESRIQSYSPQAFKFF HHHHHHHCHHHHHHH | 18.78 | 25159151 | |
| 662 | Ubiquitination | QQRLHRKKQLENEMM HHHHHHHHHHHHHHH | 61.13 | 29967540 | |
| 674 | Phosphorylation | EMMRVGLSQDAQDQM HHHHHCCCHHHHHHH | 21.78 | 17525332 | |
| 688 | Ubiquitination | MRKMLCQKESNYIRL HHHHHHHHHHHHHHH | 63.21 | 29967540 | |
| 728 | Ubiquitination | LARKVDTKALYATKT HHCCCCHHHHHHCCC | 31.75 | 29967540 | |
| 734 | Ubiquitination | TKALYATKTLRKKDV HHHHHHCCCHHHHHH | 37.07 | 29967540 | |
| 751 | Sumoylation | RNQVAHVKAERDILA HCHHHHHHHHHHHHH | 34.36 | - | |
| 792 | Phosphorylation | IPGGDMMSLLIRMGI CCCCCHHHHHHHCCC | 17.24 | - | |
| 830 | Sumoylation | GFIHRDIKPDNILID CCCCCCCCCCCEEEC | 51.08 | - | |
| 859 | Phosphorylation | GFRWTHDSKYYQSGD CCCCCCCCCCCCCCC | 18.23 | 29496907 | |
| 860 | Ubiquitination | FRWTHDSKYYQSGDH CCCCCCCCCCCCCCC | 54.77 | - | |
| 861 | Phosphorylation | RWTHDSKYYQSGDHP CCCCCCCCCCCCCCC | 15.64 | 29496907 | |
| 864 | Phosphorylation | HDSKYYQSGDHPRQD CCCCCCCCCCCCCCC | 30.02 | - | |
| 872 | Phosphorylation | GDHPRQDSMDFSNEW CCCCCCCCCCCCCCC | 16.35 | 15688006 | |
| 876 | Phosphorylation | RQDSMDFSNEWGDPS CCCCCCCCCCCCCHH | 29.58 | 24043423 | |
| 883 | Phosphorylation | SNEWGDPSSCRCGDR CCCCCCHHHCCCCCC | 46.97 | 24043423 | |
| 884 | Phosphorylation | NEWGDPSSCRCGDRL CCCCCHHHCCCCCCC | 15.80 | 24043423 | |
| 909 | Phosphorylation | HQRCLAHSLVGTPNY HHHHHHHHCCCCCCC | 21.10 | 25850435 | |
| 913 | Phosphorylation | LAHSLVGTPNYIAPE HHHHCCCCCCCCCHH | 10.81 | 25850435 | |
| 967 | Phosphorylation | MKVINWQTSLHIPPQ HEEEEEECCCCCCCC | 25.52 | 15688006 | |
| 976 | Ubiquitination | LHIPPQAKLSPEASD CCCCCCCCCCHHHHH | 44.22 | 29967540 | |
| 982 | Phosphorylation | AKLSPEASDLIIKLC CCCCHHHHHHHHHHH | 31.15 | - | |
| 1005 | Ubiquitination | KNGADEIKAHPFFKT CCCCHHHHCCCCCEE | 38.30 | 29967540 | |
| 1012 | Phosphorylation | KAHPFFKTIDFSSDL HCCCCCEECCCCHHH | 22.18 | 15688006 | |
| 1029 | Ubiquitination | QSASYIPKITHPTDT HCHHCCCCCCCCCCC | 51.16 | 29967540 | |
| 1046 | Ubiquitination | FDPVDPDKLWSDDNE CCCCCHHHCCCCCCC | 58.19 | 29967540 | |
| 1049 | Phosphorylation | VDPDKLWSDDNEEEN CCHHHCCCCCCCCCC | 45.59 | 15688006 | |
| 1060 | Phosphorylation | EEENVNDTLNGWYKN CCCCCHHHHCHHHHC | 19.54 | 15688006 | |
| 1076 | Phosphorylation | KHPEHAFYEFTFRRF CCCCCEEEEEEEHHH | 15.77 | 23917254 | |
| 1079 | Phosphorylation | EHAFYEFTFRRFFDD CCEEEEEEEHHHCCC | 12.32 | 10673337 | |
| 1099 | Phosphorylation | NYPKPIEYEYINSQG CCCCCEEEEEECCCC | 18.10 | 20873877 | |
| 1101 | Phosphorylation | PKPIEYEYINSQGSE CCCEEEEEECCCCCC | 12.42 | 29978859 | |
| 1104 | Phosphorylation | IEYEYINSQGSEQQS EEEEEECCCCCCCCC | 26.76 | 20873877 | |
| 1107 | Phosphorylation | EYINSQGSEQQSDED EEECCCCCCCCCCCC | 25.29 | 20873877 | |
| 1111 | Phosphorylation | SQGSEQQSDEDDQNT CCCCCCCCCCCCCCC | 42.53 | 25159151 | |
| 1118 | Phosphorylation | SDEDDQNTGSEIKNR CCCCCCCCCHHHCCC | 36.13 | 28270605 | |
| 1120 | Phosphorylation | EDDQNTGSEIKNRDL CCCCCCCHHHCCCCC | 33.82 | 28270605 | |
| 1129 | Phosphorylation | IKNRDLVYV------ HCCCCCEEC------ | 14.03 | 23917254 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 464 | S | Phosphorylation | Kinase | NUAK1 | O60285 | Uniprot |
| 464 | S | Phosphorylation | Kinase | NUAK2 | Q9H093 | Uniprot |
| 490 | T | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| 613 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| 674 | S | Phosphorylation | Kinase | LATS1 | O95835 | PSP |
| 872 | S | Phosphorylation | Kinase | STK3 | Q13188 | GPS |
| 909 | S | Phosphorylation | Kinase | LATS1 | O95835 | PSP |
| 909 | S | Phosphorylation | Kinase | STK3 | Q13188 | GPS |
| 967 | T | Phosphorylation | Kinase | STK3 | Q13188 | GPS |
| 1012 | T | Phosphorylation | Kinase | STK3 | Q13188 | GPS |
| 1049 | S | Phosphorylation | Kinase | LATS1 | O95835 | PSP |
| 1060 | T | Phosphorylation | Kinase | STK3 | Q13188 | GPS |
| 1079 | T | Phosphorylation | Kinase | HGK | O95819 | PSP |
| 1079 | T | Phosphorylation | Kinase | STK3 | Q13188 | GPS |
| - | K | Ubiquitination | E3 ubiquitin ligase | ITCH | Q96J02 | PMID:21383157 |
| - | K | Ubiquitination | E3 ubiquitin ligase | NEDD4 | P46934 | PMID:24107629 |
| - | K | Ubiquitination | E3 ubiquitin ligase | WWP1 | Q9H0M0 | PMID:23573293 |
| - | K | Ubiquitination | E3 ubiquitin ligase | DCAF1 | Q9Y4B6 | PMID:25026211 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LATS1_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Regulation of ploidy and senescence by the AMPK-related kinaseNUAK1."; Humbert N., Navaratnam N., Augert A., Da Costa M., Martien S.,Wang J., Martinez D., Abbadie C., Carling D., de Launoit Y., Gil J.,Bernard D.; EMBO J. 29:376-386(2010). Cited for: FUNCTION, PHOSPHORYLATION AT SER-464, AND MUTAGENESIS OF SER-464. | |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-464, AND MASSSPECTROMETRY. | |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181; THR-246; THR-261;SER-462; SER-464; THR-612 AND SER-613, AND MASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244; THR-246 ANDSER-464, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-246; SER-278 ANDSER-464, AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-246; SER-464 ANDSER-613, AND MASS SPECTROMETRY. | |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-674, AND MASSSPECTROMETRY. | |
| "The Ste20-like kinase Mst2 activates the human large tumor suppressorkinase Lats1."; Chan E.H.Y., Nousiainen M., Chalamalasetty R.B., Schaefer A.,Nigg E.A., Sillje H.H.W.; Oncogene 24:2076-2086(2005). Cited for: PHOSPHORYLATION AT SER-909 AND THR-1079. | |
| "Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244, AND MASSSPECTROMETRY. | |
| "Tyrosine phosphorylated Par3 regulates epithelial tight junctionassembly promoted by EGFR signaling."; Wang Y., Du D., Fang L., Yang G., Zhang C., Zeng R., Ullrich A.,Lottspeich F., Chen Z.; EMBO J. 25:5058-5070(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-277, AND MASSSPECTROMETRY. | |